Occupational asthma due to hexahydrophthalic anhydride: a case report C B E Chee, H S Lee, T H Cheong, Y T Wang, S C Poh Hexahydrophthalic anhydride (HHPA) belongs to the family of acid anhydrides, the members of which are reactive organic chemicals of low molecular weight widely used in alkyd and epoxy resins. The major toxic effects ofthe acid anhydrides are mucosal and skin irritation and respiratory hypersensitivity, particularly asthma. Most of the reported cases of asthma caused by acid anhydrides were due to phthalic anhydride. Cases of asthma caused by tetrachlorophthalic anhydride, himic anhydride, maleic anhydride, and pyromellitic dianhydride have also been reported. ' Although HHPA has been implicated as a cause ofasthma in a study by Moller et al, this was based on clinical histories obtained from four out of 27 workers exposed to HHPA and the finding of specific IgE to HHPA in 44% of these exposed workers.2 In none of these cases was the diagnosis confirmed by specific challenge testing.
We report a case of asthma induced by occupational exposure to HHPA who showed a bronchoconstrictive response to specific inhalation challenge with HHPA. To our knowledge, this is the first such reported case. On the second day, provocation testing was carried out with the patient standing over the same tin, which this time contained about 200 ml of pure HHPA. The tin was heated for 10 minutes up to a maximum of 92°C. After five minutes of exposure, the patient experienced cough, lacrimation, and chest tightness, with rhonchi heard in the lungs. His PEFR dropped from a baseline of 470 1/min to 315 1/min (a fall of 33%) and continued to fall to 278 1/min (a fall of 41 %) at ten minutes, when exposure to HHPA was stopped. After a further five minutes, his symptoms worsened with his PEFR falling to 215 I/min (a fall of 54%). He required two doses of ventolin nebulisation for relief of his breathlessness.
He remained relatively comfortable until six hours later when he again experienced breathlessness with rhonchi heard in the lungs, with his PEFR falling to 145 1/min (a fall of69% from a baseline of470 1/min).
Nebulised ventolin was administered and relieved his symptoms. Sixteen hours later he was awakened in the middle of the night with a severe asthmatic attack. He was unable to record his PEFR. The attack was again relieved by nebulised ventolin (fig 2) . Two of us, who were standing next to him throughout the ten minutes of exposure to heated HHPA, did not develop any respiratory symptoms.
Several days after the challenge testing, he was again admitted with poor control of his asthmatic symptoms and required systemic corticosteroids for control of his asthma.
OTHER INVESTIGATIONS
The patient's total white cell count was 13 9 x 109/1, of which 3% were eosinophils. His chest x ray film was normal. Skin prick tests to common environmental allergens were positive to house dust and house dust mite.
Discussion
Our patient experienced an immediate and delayed reaction as well as a nocturnal attack of asthma in response to challenge testing to HHPA. This dual response is characteristic of most of the reported cases of asthma caused by the acid anhydrides.' That our patient had an increase in bronchial hyperreactivity after the challenge was evidenced by his nocturnal asthmatic attack and his readmission several days later for poorly controlled symptoms. An association of the late asthmatic response with non-specific bronchial hyperresponsiveness has been shown in one previous study with acid anhydrides.'
Most cases of acid anhydride induced asthma appeared to develop in the first few years of exposure. This was also the case in our patient who developed symptoms several months after exposure to HHPA.
Our patient was atopic. Whether this predisposed him to develop asthma to the HHPA is uncertain. So far no study of asthma caused by acid anhydrides has noted any strong association with atopy.1
Allergic contact dermatitis to HHPA has been reported based on positive patch tests to HHPA. 4 This first report of a documented asthmatic response to HHPA based on a specific challenge test together with the demonstration of HHPA specific IgE by other studies25 provides good evidence for the inclusion of HHPA as a cause of occupational asthma.
We thank Dr S L Gan for referring this patient for investigation of occupational asthma. 
